awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38234236-F6712F83-3D2D-4D2A-BFFB-C23E7614EABA
Q38234236-F6712F83-3D2D-4D2A-BFFB-C23E7614EABA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38234236-F6712F83-3D2D-4D2A-BFFB-C23E7614EABA
Benefit-risk assessment of orlistat in the treatment of obesity.
P2860
Q38234236-F6712F83-3D2D-4D2A-BFFB-C23E7614EABA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38234236-F6712F83-3D2D-4D2A-BFFB-C23E7614EABA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0944eeac6cbd151396c1bde3a5df2e5cc86d4145
P2860
Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.